Clinical Trial Update: Subcutaneous Testosterone Project [Phase 1, Phase 2]

View source ↗

Summary

The University of British Columbia reports that Phase 1 and Phase 2 trials of a subcutaneous testosterone formulation for gender dysphoria have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gender Dysphoria

Drugs mentioned

• Subcutaneous Testosterone (testosterone)

Snippet

Sponsor: University of British Columbia | Conditions: Gender Dysphoria | Phase 1, Phase 2 | Status: COMPLETED